Akermin says that it is moving forward with the development of a biocatalyst-based carbon capture technology with a plan for a pilot project at the National Carbon Capture Centre in the USA.

The USA-based company has signed an agreement with Southern Company Services to install and operate a pilot plant incorporating its technology in order to assess its performance over an extended period. It says that it has achieved “excellent performance” from a bench-scale prototype that has been operating on a continuous basis for several months.

“This project signifies Akermin’s transition from laboratory testing and development to field pilot testing and demonstration marking a key step towards commercialization of our technology.” said Barry Blackwell, Akermin President & CEO. “The results from this pilot project will help to prove the viability of our technology to capture carbon dioxide from industrial processes and accelerate development of commercial partnerships and future demonstration projects covering multiple market applications.”

The pilot plant will capture carbon dioxide from the flue gas of a coal fired power plant and is on schedule to be commissioned in the fourth quarter of this year. It will operate for up to six months, during which time Akermin will collect data on parameters such as energy consumption, biocatalyst performance, carbon dioxide removal and capture of residual SOx and NOx emissions.

The biocatalyst technology uses an enzyme to remove carbon dioxide from flue gas.